This gentle dosing strategy allows patients to experience therapeutic benefits with improved tolerability, making it a sustainable option for those seeking long-term support for inflammatory and metabolic health under medical supervision
Long-Term Maintenance Once goals are achieved, we help determine a maintenance strategy that supports sustainable results
3-5 Microbial metabolites, such as secondary bile acids, short-chain fatty acids, lipopolysaccharide and others within the gut microbiota, trigger GLP-1 secretion
SafeCell an acetylated form of glutathione developed by Tesseract Medical Research, transcends these common absorption issues
A proper clinic screens for allergies, medications, and kidney or liver conditions before treatment to minimize these risks